e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
Fischer Aryeh, Collard Harold R., Cottin Vincent
Source:
Eur Respir J 2016; 47: 1295-1296
Journal Issue:
April
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fischer Aryeh, Collard Harold R., Cottin Vincent. Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur Respir J 2016; 47: 1295-1296
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort.
Source: International Congress 2017 – Novel and old entities
Year: 2017
Interstitial pneumonia with autoimmune features: a new classification still on the move
Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018
Year: 2018
Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria
Source: Eur Respir J 2016; 48: 1811-1813
Year: 2016
A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria
Source: Eur Respir J 2016; 48: 1813-1814
Year: 2016
Interstitial pneumonia with autoimmune features: challenges and controversies
Source: Eur Respir Rev, 30 (162) 210177; 10.1183/16000617.0177-2021
Year: 2021
Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Characterisation of patients with interstitial pneumonia with autoimmune features
Source: Eur Respir J 2016; 47:1767-1775
Year: 2016
Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases
Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias
Year: 2006
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Interstitial pneumonia with autoimmune features (IPAF): a clinical entity?
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections
Source: Eur Respir J 2001; 18: 101S-106S
Year: 2001
Interstitial pneumonia with autoimmune features
Source: Eur Respir Monogr 2019; 86: 140-152
Year: 2019
Interstitial pneumonia with autoimmune features
Source: Guideline 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept